Live Breaking News & Updates on Fairhaven pharmaceuticals inc

Liminal BioSciences Provides R&D Update

/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Company has nominated a lead.

United-kingdom , Cambridge , Cambridgeshire , Canada , Fairhaven , Newfoundland , Bruce-pritchard , Liminal-biosciences-inc , Fairhaven-pharmaceuticals-inc , World-health-organisation , Agonist-development-program , Nasdaq

Liminal BioSciences Inc.: Liminal BioSciences Provides R&D Update

LMNL6326 nominated as lead preclinical candidate for OXER1 antagonist development program, targeting the treatment of eosinophil-driven diseasesAdvancement of clinical trial application (CTA)

United-kingdom , Cambridge , Cambridgeshire , Canada , Fairhaven , Newfoundland , Canadian , Shrinal-inamdar , Bruce-pritchard , Kaitlin-gallagher , Exchange-commission , World-health-organisation

Liminal BioSciences (LMNL) Provides R&D Update

Liminal BioSciences (LMNL) Provides R&D Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Fairhaven , Newfoundland , Canada , United-kingdom , Canadian , Bruce-pritchard , Nasdaq , Liminal-biosciences-inc , Market-watch-research , Fairhaven-pharmaceuticals-inc , World-health-organisation , Agonist-development-program

Form 8-K Zymeworks Inc. For: May 17

Form 8-K Zymeworks Inc. For: May 17
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , British , Neil-klompas , Kenneth-galbraith , Prometic-life-sciences-inc , Corners-capital-inc , Zymeworks-bc-inc , Liminal-biosciences-inc , Company-zymeworks , Fairhaven-pharmaceuticals-inc , Residence-at-syncona , University-of-british-columbia